Recently, NewPro Bioworks announced the completion of pre-A round financing of tens of millions of yuan. This round of financing was jointly led by Shanghai SDIC and Ultron Pilot Fund. At the same time, the precision fermented lactoferrin product independently developed by the company was officially certified by the US FDA Self-GRAs, marking a key breakthrough in the entry of its core products into the international market.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.